Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-04-16 00:41:48 ET
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call April 15, 2026 4:30 PM EDT
Company Participants
Iain Dukes - CEO, Secretary & Director
Charles Parker - Chief Financial Officer
Conference Call Participants
John Fraunces - Lifesci Advisors, LLC
Presentation
Operator ...
Ladies and gentlemen, thank you for standing by. Welcome to the Traws [Technical Difficulty].
[Operator Instructions]
As a reminder, this call is recorded. I would now like to turn the call over to John Fraunces, LifeSci Advisors.
Read the full article on Seeking Alpha
For further details see:
Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript
Traws Pharma Inc.
NASDAQ: TRAW
TRAW Trading
8.13% G/L:
$1.6869 Last:
571,383 Volume:
$1.55 Open:
TRAW Latest News
May 15, 2026 07:00:00 am
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial ResultsMay 08, 2026 07:30:00 am
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus InfectionsApril 15, 2026 04:01:00 pm
Traws Pharma Reports Full Year 2025 Results and Provides Business HighlightsTRAW Stock Data
$15,422,373
6,872,146
2.64%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Newtown
